Cite
Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type II
MLA
Pranesh Chakraborty, et al. “Development of a Clinical Assay for Detection of GAA Mutations and Characterization of the GAA Mutation Spectrum in a Canadian Cohort of Individuals with Glycogen Storage Disease, Type II.” Molecular Genetics and Metabolism, vol. 92, no. 4, May 2007. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c25c352147c2edd6ea4f35b337d501b9&authtype=sso&custid=ns315887.
APA
Pranesh Chakraborty, Joe T.R. Clarke, Robin Casey, C. A. Rupar, Nancy Carson, Alicia K. J. Chan, John W. Callahan, Michael T. Geraghty, M.E. McCready, M.A. Skomorowski, & Fiona Bamforth. (2007). Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type II. Molecular Genetics and Metabolism, 92(4).
Chicago
Pranesh Chakraborty, Joe T.R. Clarke, Robin Casey, C. A. Rupar, Nancy Carson, Alicia K. J. Chan, John W. Callahan, et al. 2007. “Development of a Clinical Assay for Detection of GAA Mutations and Characterization of the GAA Mutation Spectrum in a Canadian Cohort of Individuals with Glycogen Storage Disease, Type II.” Molecular Genetics and Metabolism 92 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c25c352147c2edd6ea4f35b337d501b9&authtype=sso&custid=ns315887.